The "Golden Hour" and Acute Brain Ischemia Presenting Features and Lytic Therapy in >30 000 Patients Arriving Within 60 Minutes of Stroke Onset

被引:156
作者
Saver, Jeffrey L. [1 ]
Smith, Eric E. [2 ]
Fonarow, Gregg C. [3 ]
Reeves, Mathew J. [4 ]
Zhao, Xin [5 ]
Olson, DaiWai M. [5 ]
Schwamm, Lee H. [6 ]
机构
[1] Univ Calif Los Angeles, Stroke Ctr, Dept Neurol, Los Angeles, CA 90095 USA
[2] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada
[3] Univ Calif Los Angeles, Div Cardiol, Los Angeles, CA 90095 USA
[4] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA
[5] Duke Univ, Clin Res Ctr, Durham, NC USA
[6] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA
关键词
acute care; acute therapy; acute stroke; emergency medical services; emergency medicine; stroke care; stroke delivery; therapy; thrombolysis; thrombolytic therapy; TISSUE-PLASMINOGEN ACTIVATOR; CARE; THROMBOLYSIS; ALTEPLASE; TIME; RECOMMENDATIONS;
D O I
10.1161/STROKEAHA.110.583815
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-The benefit of intravenous thrombolytic therapy in acute brain ischemia is strongly time dependent. Methods-The Get With the Guidelines-Stroke database was analyzed to characterize ischemic stroke patients arriving at hospital Emergency Departments within 60 minutes of the last known well time from April 1, 2003, to December 30, 2007. Results-During the 4.75-year study period, among 253 148 ischemic stroke patients arriving directly by ambulance or private vehicle at 905 hospital Emergency Departments, 106 924 (42.2%) had documented, exact last known well times. Onset to door time was <= 60 minutes in 30 220 (28.3%), 61 to 180 minutes in 33 858 (31.7%), and >180 minutes in 42 846 (40.1%). Features most strongly distinguishing the patients arriving at <= 60, 61 to 180, and >180 minutes were greater stroke severity (median National Institutes of Health Stroke Scale score, 8.0 vs 6.0 vs 4.0, P<0.0001) and more frequent arrival by ambulance (79.0%. vs 72.2% vs 55.0%, P<0.0001). Compared with patients arriving at 61 to 180 minute, "golden hour" patients received intravenous thrombolytic therapy more frequently (27.1% vs 12.9%; odds ratio=2.51; 95% CI, 2.41-2.61; P<0.0001), but door-to-needle time was longer (mean, 90.6 vs 76.7 minutes, P<0.0001). A door-to-needle time of <= 60 minutes was achieved in 18.3% of golden hour patients. Conclusions-At Get With the Guidelines-Stroke hospital Emergency Departments, more than one quarter of patients with documented onset time and at least one eighth of all ischemic stroke patients arrived within 1 hour of onset, where they received thrombolytic therapy more frequently but more slowly than late arrivers. These findings support public health initiates to increase early presentation and shorten door-to-needle times in patients arriving within the golden hour. (Stroke. 2010;41:1431-1439.)
引用
收藏
页码:1431 / 1439
页数:9
相关论文
共 27 条
  • [1] Intravenous tissue-type plasminogen activator for treatment of acute stroke - The standard treatment with alteplase to reverse stroke (STARS) study
    Albers, GW
    Bates, VE
    Clark, WM
    Bell, R
    Verro, P
    Hamilton, SA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (09): : 1145 - 1150
  • [2] *AM HOSP ASS, 2007, AM HOSP ASS HOSP STA
  • [3] [Anonymous], P NAT S RAP ID TREAT
  • [4] A systems approach to immediate evaluation and management of hyperacute stroke - Experience at eight centers and implications for community practice and patient care
    Brott, T
    Broderick, J
    Kothari, R
    ODonoghue, M
    Barsan, W
    Tomsick, T
    Spilker, J
    Miller, R
    Sauerbeck, L
    Farrell, J
    Kelly, J
    Perkins, T
    McDonald, T
    Rorick, M
    Hickey, C
    Armitage, J
    Perry, C
    Thalinger, K
    Rhude, R
    Schill, J
    Becker, PS
    Heath, RS
    Adams, D
    Reed, R
    Klei, M
    Hughes, A
    Anthony, J
    Baudendistel, D
    Zadicoff, C
    Rymer, M
    Bettinger, I
    Laubinger, P
    Schmerler, M
    Meiros, G
    Lyden, P
    Dunford, J
    Zivin, J
    Rapp, K
    Babcock, T
    Daum, P
    Persona, D
    Brody, M
    Jackson, C
    Lewis, S
    Liss, J
    Mahdavi, Z
    Rothrock, J
    Tom, T
    Zweifler, R
    Kobayashi, J
    [J]. STROKE, 1997, 28 (08) : 1530 - 1540
  • [5] Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator A Science Advisory From the American Heart Association/American Stroke Association
    del Zoppo, Gregory J.
    Saver, Jeffrey L.
    Jauch, Edward C.
    Adams, Harold P., Jr.
    [J]. STROKE, 2009, 40 (08) : 2945 - 2948
  • [6] *ESO EX COMM, 2009, EUR STROK ORG GUID U
  • [7] A comprehensive review of prehospital and in-hospital delay times in acute stroke care
    Evenson, K. R.
    Foraker, R. E.
    Morris, D. L.
    Rosamond, W. D.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2009, 4 (03) : 187 - 199
  • [8] George Mary G., 2009, Morbidity and Mortality Weekly Report, V58, P1
  • [9] Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
    Hacke, Werner
    Kaste, Markku
    Bluhmki, Erich
    Brozman, Miroslav
    Davalos, Antoni
    Guidetti, Donata
    Larrue, Vincent
    Lees, Kennedy R.
    Medeghri, Zakaria
    Machnig, Thomas
    Schneider, Dietmar
    von Kummer, Ruediger
    Wahlgren, Nils
    Toni, Danilo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (13) : 1317 - 1329
  • [10] Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study
    Hill, MD
    Buchan, AM
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (10) : 1307 - 1312